# IMPLEMENTATION STATUS & DEVELOPMENT PROGRESSION
## Comprehensive Audit of Implemented, Experimental, Deprecated, and Planned Features
**Status:** `VERIFIED — CURRENT IMPLEMENTATION`  

---

### 1. Implementation Status Ledger

```text
===================================================================================================
COMPONENT / FEATURE                      STATUS               CODE / ARTIFACT LOCATION
===================================================================================================
1. Target mRNA Sequence Ingestion        IMPLEMENTED          smepred/src/parser.py
2. Overlapping 21-mer Sliding Generator  IMPLEMENTED          smepred/src/sirna_generator.py
3. Model A Naked LightGBM (214-D)        IMPLEMENTED          smepred/models/model_normal.txt
4. Context-Aware Secondary Structure     IMPLEMENTED          smepred/src/context_feature_extractor.py
5. ORF Domain Partitioning & Curated Lead IMPLEMENTED         smepred/src/predictor.py:select_curated_leads
6. Positional NucSlot Data Schema        IMPLEMENTED          smepred/src/chem_schema.py
7. 517-D Multi-Modal Feature Extractor   IMPLEMENTED          smepred/src/features_v4.py
8. Single Unified Dose-Aware CatBoost    IMPLEMENTED          smepred/models/unified_dose_catboost.cbm
9. Closed-Form Analytical Hill Inversion IMPLEMENTED          smepred/src/predictor.py:808-811
10. Deterministic 4-Domain Guardrails    IMPLEMENTED          smepred/src/biophysics.py
11. 2-Bit SIMD Whole-Transcriptome Index IMPLEMENTED          smepred/src/offtarget.py
12. Single-Mod Permutation Scanner (812) IMPLEMENTED          smepred/src/modification_engine.py
13. Combinatorial Beam Optimizer (W=20)  IMPLEMENTED          smepred/src/modification_engine.py
14. Continuous A-Form 3D PDB Generator   IMPLEMENTED          smepred/src/pdb_generator.py
15. FastAPI Production REST Microservice IMPLEMENTED          smepred/api/main.py
16. Vanilla HTML/CSS/JS Single-Page App  IMPLEMENTED          smepred/app.html
17. Embedded 3Dmol.js WebGL Viewer       IMPLEMENTED          smepred/app.html:8,3Dmol-min.js
---------------------------------------------------------------------------------------------------
18. LLM Scientific Assistant Co-Pilot    PARTIALLY IMPLEMENTED smepred/src/assistant_service.py (Requires API Key)
19. Solid-Phase Synthesis Yield Filter   PARTIALLY IMPLEMENTED smepred/src/biophysics.py (Heuristic Rules)
20. In Silico 3D Ago2 Protein Docking    EXPERIMENTAL         paper_figures/ago2_3d_docking_complex.png
21. Structure Energy Minimization        EXPERIMENTAL         smepred/src/structure_minimization.py
---------------------------------------------------------------------------------------------------
22. MEG-mod GNN TransformerConv Engine   DEPRECATED / RETIRED MEG-mod-main/finetuned_v2.pt
23. IEEE v5 Two-Stage Cascading Engine   DEPRECATED / RETIRED helixzero_ieee_v5/
24. Legacy 577-D Feature Extractor (Ernie) DEPRECATED         smepred/src/features_v4.py:build_features_v4
---------------------------------------------------------------------------------------------------
25. Stereopure Chiral PS Modeling (Rp/Sp) PLANNED              Roadmap (docs/25_FUTURE_WORK.md)
26. Extrahepatic PK/PD Multi-Task Models PLANNED              Roadmap (docs/25_FUTURE_WORK.md)
27. Automated Synthesizer Workcell Hook  PLANNED              Roadmap (docs/25_FUTURE_WORK.md)
===================================================================================================
```

---

### 2. Development Progression Milestones

1. **Phase 1: Proof-of-Concept & Naked Sequence Baseline (Q1 2026)**
   - Constructed Model A on Huesken 2005 qPCR data.
   - Verified that sequence features predict naked efficacy ($r = 0.8044$).
   - Discovered that Model A collapses on chemically modified siRNAs ($r = 0.1771$), establishing the necessity of chemistry-aware modeling.

2. **Phase 2: Deep Learning Hybrid & Graph Exploration (Q2 2026)**
   - Explored PyG `TransformerConv` bi-directional graph attention networks (MEG-mod).
   - Identified severe out-of-distribution transfer degradation ($r = 0.0631$) and 15-minute cold starts.
   - Decision: Isolate GNN in `MEG-mod-main/` for ablation comparison and pivot to GBDT tabular representations.

3. **Phase 3: Two-Stage Cascading Formulation (Q3 2026)**
   - Developed IEEE v5 two-stage architecture ($pIC_{50} \to \text{Hill}$).
   - Discovered that intermediate potency prediction propagated variance ($r = 0.8187$).
   - Decision: Retire two-stage cascade and formulate unified dose conditioning.

4. **Phase 4: Flagship Unified Dose-Aware Architecture (October 2026)**
   - Formulated 517-D multi-modal vector space with continuous $\log_{10}(\text{Dose\_nM})$ conditioning.
   - Trained unified CatBoost regressor on 17,761 samples with zero sequence leakage `GroupKFold` across 5,251 disjoint clusters ($r = 0.8359$ held-out).
   - Achieved 100% sensitivity on all 6 FDA commercial therapeutics.
   - Consolidated single source of truth in `final_benchmarks/`.
